240 related articles for article (PubMed ID: 16098463)
1. Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity.
Moeller BJ; Dreher MR; Rabbani ZN; Schroeder T; Cao Y; Li CY; Dewhirst MW
Cancer Cell; 2005 Aug; 8(2):99-110. PubMed ID: 16098463
[TBL] [Abstract][Full Text] [Related]
2. Engaging the vascular component of the tumor response.
Fuks Z; Kolesnick R
Cancer Cell; 2005 Aug; 8(2):89-91. PubMed ID: 16098459
[TBL] [Abstract][Full Text] [Related]
3. Activation of hypoxia-inducible factor-1 in bacillary angiomatosis: evidence for a role of hypoxia-inducible factor-1 in bacterial infections.
Kempf VA; Lebiedziejewski M; Alitalo K; Wälzlein JH; Ehehalt U; Fiebig J; Huber S; Schütt B; Sander CA; Müller S; Grassl G; Yazdi AS; Brehm B; Autenrieth IB
Circulation; 2005 Mar; 111(8):1054-62. PubMed ID: 15723970
[TBL] [Abstract][Full Text] [Related]
4. HIF at the crossroads between ischemia and carcinogenesis.
Paul SA; Simons JW; Mabjeesh NJ
J Cell Physiol; 2004 Jul; 200(1):20-30. PubMed ID: 15137054
[TBL] [Abstract][Full Text] [Related]
5. Observation of incipient tumor angiogenesis that is independent of hypoxia and hypoxia inducible factor-1 activation.
Cao Y; Li CY; Moeller BJ; Yu D; Zhao Y; Dreher MR; Shan S; Dewhirst MW
Cancer Res; 2005 Jul; 65(13):5498-505. PubMed ID: 15994919
[TBL] [Abstract][Full Text] [Related]
6. Role of hypoxia in tumor angiogenesis-molecular and cellular angiogenic crosstalk.
Acker T; Plate KH
Cell Tissue Res; 2003 Oct; 314(1):145-55. PubMed ID: 12898211
[TBL] [Abstract][Full Text] [Related]
7. Targeting HIF-1 for cancer therapy.
Semenza GL
Nat Rev Cancer; 2003 Oct; 3(10):721-32. PubMed ID: 13130303
[TBL] [Abstract][Full Text] [Related]
8. HIFs, hypoxia, and vascular development.
Covello KL; Simon MC
Curr Top Dev Biol; 2004; 62():37-54. PubMed ID: 15522738
[TBL] [Abstract][Full Text] [Related]
9. Cell-permeable hypoxia-inducible factor-1 (HIF-1) antagonists function as tumor radiosensitizers.
Shi M; Guo XT; Shu MG; Chen FL; Li LW
Med Hypotheses; 2007; 69(1):33-5. PubMed ID: 17280792
[TBL] [Abstract][Full Text] [Related]
10. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules.
Moeller BJ; Cao Y; Li CY; Dewhirst MW
Cancer Cell; 2004 May; 5(5):429-41. PubMed ID: 15144951
[TBL] [Abstract][Full Text] [Related]
11. Targeting tumors through the HIF system.
Ratcliffe PJ; Pugh CW; Maxwell PH
Nat Med; 2000 Dec; 6(12):1315-6. PubMed ID: 11100107
[No Abstract] [Full Text] [Related]
12. Evaluating hypoxia-inducible factor-1alpha as a cancer therapeutic target via inducible RNA interference in vivo.
Li L; Lin X; Staver M; Shoemaker A; Semizarov D; Fesik SW; Shen Y
Cancer Res; 2005 Aug; 65(16):7249-58. PubMed ID: 16103076
[TBL] [Abstract][Full Text] [Related]
13. Poly(ADP-ribose) polymerase 1 promotes tumor cell survival by coactivating hypoxia-inducible factor-1-dependent gene expression.
Elser M; Borsig L; Hassa PO; Erener S; Messner S; Valovka T; Keller S; Gassmann M; Hottiger MO
Mol Cancer Res; 2008 Feb; 6(2):282-90. PubMed ID: 18314489
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral hypoxia, radiation resistance, and HIF-1.
Semenza GL
Cancer Cell; 2004 May; 5(5):405-6. PubMed ID: 15144945
[TBL] [Abstract][Full Text] [Related]
15. A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer.
Lee BL; Kim WH; Jung J; Cho SJ; Park JW; Kim J; Chung HY; Chang MS; Nam SY
Carcinogenesis; 2008 Jan; 29(1):44-51. PubMed ID: 17984117
[TBL] [Abstract][Full Text] [Related]
16. Significance of HIF-1-active cells in angiogenesis and radioresistance.
Harada H; Kizaka-Kondoh S; Li G; Itasaka S; Shibuya K; Inoue M; Hiraoka M
Oncogene; 2007 Nov; 26(54):7508-16. PubMed ID: 17563752
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor-1alpha promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts.
Dang DT; Chen F; Gardner LB; Cummins JM; Rago C; Bunz F; Kantsevoy SV; Dang LH
Cancer Res; 2006 Feb; 66(3):1684-936. PubMed ID: 16452228
[TBL] [Abstract][Full Text] [Related]
18. New drugs target hypoxia response in tumors.
Garber K
J Natl Cancer Inst; 2005 Aug; 97(15):1112-4. PubMed ID: 16077066
[No Abstract] [Full Text] [Related]
19. Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells.
Alqawi O; Moghaddas M; Singh G
Prostate Cancer Prostatic Dis; 2006; 9(2):126-35. PubMed ID: 16432534
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
Forooghian F; Das B
Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
